Breaking News

Cognizant and Boehringer Ingelheim Launch One Medicine Platform

The unified platform brings together data and processes across clinical, regulatory, and quality, enabling Boehringer to streamline its product development.

Author Image

By: Charlie Sternberg

Associate Editor

Cognizant and Boehringer Ingelheim have launched an end-to-end technology platform powered by the Veeva Development Cloud, designed to accelerate Boehringer Ingelheim’s delivery of life-transforming treatments. The milestone marks the completion of Phase One of the collaboration, which was first announced in 2023. Boehringer’s “One Medicine Platform” replaces over 20 legacy platforms—unifying medicinal development processes and data sources into a connected ecosystem in orde...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters